Trial Profile
Phase II Study of Erlotinib (TarcevaTM) Combined With Chemoradiation and Adjuvant Chemotherapy in Patients With Resectable Pancreatic Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Jun 2020
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary) ; Capecitabine; Gemcitabine
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 05 Nov 2006 New trial record.